Condition

Alzheimers Disease, Familial clinical trials and research

• 2Clinical trials
• 15Countries

All recruiting trials (2)

• Testing a new treatment for early onset Alzheimer's disease caused by genetic mutations

  This study is testing a new drug called remternetug to see if it can help prevent or reverse early onset Alzheimer's disease in people with genetic mutations.

  Recruiting at 24 sites Phase 2/3 Washington University School of Medicine · Birmingham, Alabama and 36 other locations · NCT06647498

• Evaluating treatments for early onset Alzheimer's disease linked to genetic mutations

  This study is testing new drugs to see if they can help people with early onset Alzheimer's caused by genetic mutations by slowing down the buildup of harmful proteins in the brain.

  Recruiting at 24 sites Phase 2/3 Washington University School of Medicine · Birmingham, Alabama and 36 other locations · NCT05552157

Related topics

Quick answers

How many Alzheimers Disease, Familial clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in Argentina (2 trials), Australia (2 trials), Canada (2 trials), Colombia (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →